Skip to main content
. 2018 Sep 14;36:171–182. doi: 10.1016/j.ebiom.2018.09.007

Table 3.

Treatment interaction with the radiomics score for disease-free survival and overall survival in patients with stage II and III disease.

Radiomics score Chemo No chemo Disease-free survival
Overall survival
Yes vs No chemo, HR (95% CI) P P value for interaction Yes vs No chemo, HR (95% CI) P P value for interaction
Internal cohort (n = 293)
 High score 113 85 0.176(0.083–0.374) <0.001 0.148(0.066–0.333) <0.001
 Medium score 21 25 0.565(0.300–1.065) 0.077 <0.0001 0.717(0.381–1.352) 0.304 <0.0001
 Low score 27 22 0.871(0.576–1.318) 0.514 0.806(0.514–1.266) 0.350
External cohort (n = 854)
 High score 145 111 0.412(0.306–0.554) <0.001 <0.0001 0.394(0.293–0.529) <0.001 <0.0001
 Medium score 210 92 0.584(0.412–0.829) 0.003 0.601(0.423–0.854) 0.005
 Low score 207 89 0.788(0.489–1.269) 0.327 0.807(0.497–1.309) 0.385

Chemo: chemotherapy.